147 related articles for article (PubMed ID: 3116916)
1. Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids.
Gasser TC; Graversen PH; Madsen PO
Antimicrob Agents Chemother; 1987 Jul; 31(7):1010-3. PubMed ID: 3116916
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
Naber KG; Sörgel F; Kees F; Schumacher H; Metz R; Grobecker H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():199-207. PubMed ID: 2462556
[TBL] [Abstract][Full Text] [Related]
3. Distribution of ciprofloxacin in the dog prostate and various tissues.
Frimodt-Møller PC; Dørflinger T; Madsen PO
Urol Res; 1984; 12(6):283-6. PubMed ID: 6240821
[TBL] [Abstract][Full Text] [Related]
4. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
Kees F; Naber KG; Schumacher H; Grobecker H
Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456
[TBL] [Abstract][Full Text] [Related]
5. Amifloxacin distribution in the dog prostate.
Frimodt-Møller PC; Dørflinger T; Madsen PO
Prostate; 1985; 6(2):163-8. PubMed ID: 3975177
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of Ro 23-6240, a new fluorinated 4-quinolone.
Stobberingh EE; Houben AW; van Boven CP
Chemotherapy; 1987; 33(3):197-203. PubMed ID: 3109817
[TBL] [Abstract][Full Text] [Related]
7. Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion.
Madsen PO; Baumueller A; Hoyme U
Scand J Infect Dis Suppl; 1978; (14):145-50. PubMed ID: 279967
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal kinetics of various dosages of fleroxacin simulated in bacterial cultures.
Bauernfeind A; Eberlein E; Hörl G
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():81-9. PubMed ID: 3144553
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
Digranes A; Benonisen E; Salveson A; Zahm F
Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
Pace J; Bertasso A; Georgopapadakou NH
Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.
Akaniro JC; Vidaurre CE; Stutman HR; Marks MI
Antimicrob Agents Chemother; 1990 Oct; 34(10):1880-4. PubMed ID: 2127170
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Beskid G; Fallat V; Lipschitz ER; McGarry DH; Cleeland R; Chan K; Keith DD; Unowsky J
Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857
[TBL] [Abstract][Full Text] [Related]
13. Fleroxacin resistance in Escherichia coli.
Chapman JS; Bertasso A; Georgopapadakou NH
Antimicrob Agents Chemother; 1989 Feb; 33(2):239-41. PubMed ID: 2541657
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
Christenson JG; Chan KK; Cleeland R; Dix-Holzknecht B; Farrish HH; Patel IH; Specian A
Antimicrob Agents Chemother; 1990 Oct; 34(10):1895-900. PubMed ID: 2127171
[TBL] [Abstract][Full Text] [Related]
15. Routes of quinolone permeation in Escherichia coli.
Chapman JS; Georgopapadakou NH
Antimicrob Agents Chemother; 1988 Apr; 32(4):438-42. PubMed ID: 3132091
[TBL] [Abstract][Full Text] [Related]
16. Co-trimazine distribution in the canine prostate.
Frimodt-Möller N; Maigaard S; Madsen PO; Naber KG
Infection; 1979; 7 Suppl 4():S345-8. PubMed ID: 511347
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial substances in secretion, interstitial fluid, and tissue of normal and infected canine prostate glands.
Baumueller A; Madsen PO
Urol Res; 1982 Feb; 10(1):31-5. PubMed ID: 7200274
[TBL] [Abstract][Full Text] [Related]
18. Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
Keller N; Raponi G; Hoepelman IM; Overbeek BP; Rozenberg-Arska M; Verhoef J
Zentralbl Bakteriol; 1991 Jan; 274(4):519-26. PubMed ID: 1907453
[TBL] [Abstract][Full Text] [Related]
19. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of fleroxacin against Chlamydia trachomatis.
Steele-Mortimer O; Meier-Ewert H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
